D015243Chemicals & DrugsD04.210.500.247.808.197.247D10.532.599.700D10.570.938.208.285D12.776.521.622.700Cholesterol, VLDLprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfConnectionsnumber of connectionsprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierInformation Resourcevivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConcept0.09928790.09928791subject area for20922563Rosenson RS, Helenowski IB, Tangney CCCardiovascular drugs and therapyHeterogeneous postprandial lipoprotein responses in the metabolic syndrome, and response to fenofibrate therapy. Cardiovasc Drugs Ther. 2010 Dec; 24(5-6):439-47.Cardiovasc Drugs Ther2010-12-01T00:00:002010Heterogeneous postprandial lipoprotein responses in the metabolic syndrome, and response to fenofibrate therapy.